Did This Lightning-Rod Drug Go Too Far?

In this segment from Market Checkup, Motley Fool health-care analysts David Williamson and Michael Douglass discuss the continuing backlash from pharmacy benefits manager Express Scripts (NASDAQ: ESRX  ) against the price point Gilead (NASDAQ: GILD  ) has set for its blockbuster hepatitis C drug Sovaldi.

They discuss Express Scripts' position that price points like Sovaldi's aren't sustainable for customers, and they also look at the company's hints at strategic initiatives it may take if Gilead doesn't relent on Sovaldi's cost. The guys also discuss the bad news from Express Scripts' earnings report, and why the market's resulting sell-off may have been an overreaction.

Invest in the next wave of health care innovation
The Economist compares this disruptive invention to the steam engine and the printing press. Business Insider says it's "the next trillion-dollar industry." And the technology behind is poised to set off one of the most remarkable health-care revolutions in decades. The Motley Fool's exclusive research presentation dives into this technology's true potential, and its ability to make life-changing medical solutions never thought possible. To learn how you can invest in this unbelievable new technology, click here now to see our free report.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2942379, ~/Articles/ArticleHandler.aspx, 8/31/2014 12:19:50 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement